TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

101.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement WGS
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
57.8% 97.8% 107.8% 111.4% 55.6% 36.4% 30.3%
42.2% 2.2% -7.8% -11.4% 44.4% 63.6% 69.7%
17.8% 40.5% 49.6% 36.7% 28.8% 15.0% 16.8%
15.0% 56.2% 97.1% 92.1% 66.0% 33.1% 35.3%
57.7% 137.2% 202.4% 273.1% 133.6% 71.2% 72.8%
-15.5% -134.9% -210.3% -284.5% -89.2% -7.6% -2.8%
0.4% 1.4% 1.3% 1.4% 1.0% 0.6%
-15.1% -134.6% -115.6% -254.8% -87.2% -17.2% -4.9%
0.7% 2.8% 10.2% -20.9% -0.5% -0.1% 0.0%
-15.1% -134.6% -115.6% -233.9% -86.8% -17.1% -4.9%
-11.5% -126.7% -104.0% -169.7% -67.4% -9.1% 1.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?